Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Iftner

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Journal of Virology|October 29, 2020
Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex FormationMarcel Chris Conrady, Irina Suarez, Gergö Gogl, et al.
BMJ (Clinical Research Ed.)|October 15, 2008
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyJoakim Dillner, Matejka Rebolj, Philippe Birembaut, et al.
Journal of Clinical Microbiology|May 29, 2015
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in GermanyThomas Iftner, Sven Becker, Klaus-Joachim Neis, et al.
BMC Infectious Diseases|June 28, 2012
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE studyEsther Roura, Thomas Iftner, José Antonio Vidart, et al.
Plos Pathogens|January 5, 2016
Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4Maria Delcuratolo, Jasmin Fertey, Markus Schneider, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 4, 2015
Role of human papillomavirus testing and cytology in follow-up after conizationCamilla F Gosvig, Lene D Huusom, Isabelle Deltour, et al.
British Journal of Cancer|March 27, 2023
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapseSuzana Mittelstadt, Olga Kelemen, Jakob Admard, et al.
Journal of Clinical Microbiology|October 26, 2018
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in GermanyThomas Iftner, Klaus-Joachim Neis, Alejandra Castanon, et al.
Frontiers in Immunology|July 15, 2025
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant womenMadhuri S Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Journal of Virology|October 29, 2020
Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex FormationMarcel Chris Conrady, Irina Suarez, Gergö Gogl, et al.
BMJ (Clinical Research Ed.)|October 15, 2008
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyJoakim Dillner, Matejka Rebolj, Philippe Birembaut, et al.
Journal of Clinical Microbiology|May 29, 2015
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in GermanyThomas Iftner, Sven Becker, Klaus-Joachim Neis, et al.
BMC Infectious Diseases|June 28, 2012
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE studyEsther Roura, Thomas Iftner, José Antonio Vidart, et al.
Plos Pathogens|January 5, 2016
Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4Maria Delcuratolo, Jasmin Fertey, Markus Schneider, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 4, 2015
Role of human papillomavirus testing and cytology in follow-up after conizationCamilla F Gosvig, Lene D Huusom, Isabelle Deltour, et al.
British Journal of Cancer|March 27, 2023
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapseSuzana Mittelstadt, Olga Kelemen, Jakob Admard, et al.
Journal of Clinical Microbiology|October 26, 2018
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in GermanyThomas Iftner, Klaus-Joachim Neis, Alejandra Castanon, et al.
Frontiers in Immunology|July 15, 2025
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant womenMadhuri S Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Pageof 17